Eplontersen: A Breakthrough in Treating Hereditary Transthyretin-Mediated Amyloidosis

Eplontersen: A Breakthrough in Treating Hereditary Transthyretin-Mediated Amyloidosis The recent approval of eplontersen, marketed as Wainzua, marks a significant advancement in the treatment of hereditary transthyretin-mediated amyloidosis (ATTR), a rare and progressive condition that has long challenged the medical community. This disease is characterized by the accumulation of misfolded transthyretin (TTR) protein in various tissues, […]

Asthma Therapeutics Market Size to Reach USD 22.0 Billion by 2032, Impelled by Favorable Government Initiatives

Asthma Therapeutics Market Size to Reach USD 22.0 Billion by 2032, Impelled by Favorable Government Initiatives The market for asthma therapeutics is experiencing a significant surge, driven by a combination of increased awareness about the importance of treating asthma and the proactive initiatives taken by governing agencies worldwide. Governments are not only recognizing the burden […]